One Partner, All Your Solutions

It’s Pure GENius.

shadow
shadow
shadow
shadow
shadow

Celebrating its 40th anniversary in 2021, GEN remains the foundation of the biotech industry—the driver of the life sciences, the hub of the community, and the only partner you need to achieve your marketing goals. Like the industry we cover, GEN is creative, innovative, fast-moving, and flexible. We cover the present with a view to the future, ensuring our readership of decision-makers and thought-leaders possess all the information they need to be successful in their work.

65,000

Qualified Magazine Subscribers

180,000

Opted-in eNewsletter Subscribers

420,000

Engaged Website Visitors per Month

608,000

Active Followers on Facebook and Twitter

GEN moves the life science market. Let us move yours.

Our unparalleled editorial covers the full spectrum of biotechnology – from our core areas of Drug Discovery, OMICS, Genome Editing, Bioprocessing, and Translational Medicine to our new, expanded focus on the emerging areas of Cancer Research, Infectious Diseases, and Artificial Intelligence/Big Data. We provide rare insight that accelerates the pace of research, advances therapeutic developments, and triggers large-scale investments. By delivering excellence for our readers, we consistently deliver success for our clients.

What Our Customers Are Saying

Download the 2021 Media Kit